Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Data: BTC options contracts worth $37.4 billion and ETH options contracts worth $20.5 billion will expire tomorrow

Data: BTC options contracts worth $37.4 billion and ETH options contracts worth $20.5 billion will expire tomorrow

2024/01/25 02:34

According to Deribit data, BTC options with a nominal value of 3.74 billion USD will expire and be delivered tomorrow, with a Put Call Ratio of 0.52 and the greatest pain point at 41000 USD. ETH options with a nominal value of 2.05 billion USD will also expire and be delivered tomorrow, with a Put Call Ratio of 0.31 and the greatest pain point at 2300 USD.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A historic breakthrough in pancreatic cancer treatment! FDA approves RevMed's targeted new drug, with sales expected to exceed $9 billion by 2032.

The oral new drug daraxonrasib from RevMed has been officially approved by the FDA for market launch, with an annual list price exceeding $475,000. It is the first targeted drug aimed at the key molecular pathogenic mechanism of pancreatic cancer. Clinical trials show that the median survival time for patients almost doubled, increasing from 6.7 months to 13.2 months. According to data from the American Cancer Society, over 52,000 people are expected to die from pancreatic cancer this year. Wall Street predicts that sales could surpass $9 billions by 2032.

华尔街见闻2026/08/26 20:06